WYETH | PROCTER & GAMBLE HEALTH | WYETH/ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.7 | 34.5 | 80.4% | View Chart |
P/BV | x | 11.3 | 10.5 | 107.1% | View Chart |
Dividend Yield | % | 10.9 | 2.0 | 538.3% |
WYETH PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WYETH Mar-14 |
PROCTER & GAMBLE HEALTH Jun-23 |
WYETH/ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,065 | 5,366 | 19.8% | |
Low | Rs | 553 | 3,883 | 14.2% | |
Sales per share (Unadj.) | Rs | 289.5 | 740.7 | 39.1% | |
Earnings per share (Unadj.) | Rs | 38.7 | 138.2 | 28.0% | |
Cash flow per share (Unadj.) | Rs | 39.9 | 155.2 | 25.7% | |
Dividends per share (Unadj.) | Rs | 145.00 | 95.00 | 152.6% | |
Avg Dividend yield | % | 17.9 | 2.1 | 872.4% | |
Book value per share (Unadj.) | Rs | 118.5 | 447.6 | 26.5% | |
Shares outstanding (eoy) | m | 22.72 | 16.60 | 136.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.8 | 6.2 | 44.8% | |
Avg P/E ratio | x | 20.9 | 33.5 | 62.5% | |
P/CF ratio (eoy) | x | 20.3 | 29.8 | 68.0% | |
Price / Book Value ratio | x | 6.8 | 10.3 | 66.1% | |
Dividend payout | % | 374.7 | 68.7 | 545.3% | |
Avg Mkt Cap | Rs m | 18,381 | 76,761 | 23.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 359 | 2,062 | 17.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,577 | 12,296 | 53.5% | |
Other income | Rs m | 347 | 184 | 188.9% | |
Total revenues | Rs m | 6,925 | 12,480 | 55.5% | |
Gross profit | Rs m | 1,023 | 3,247 | 31.5% | |
Depreciation | Rs m | 27 | 281 | 9.7% | |
Interest | Rs m | 4 | 8 | 57.0% | |
Profit before tax | Rs m | 1,339 | 3,142 | 42.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 460 | 847 | 54.2% | |
Profit after tax | Rs m | 879 | 2,295 | 38.3% | |
Gross profit margin | % | 15.6 | 26.4 | 58.9% | |
Effective tax rate | % | 34.3 | 27.0 | 127.3% | |
Net profit margin | % | 13.4 | 18.7 | 71.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3,964 | 11,713 | 33.8% | |
Current liabilities | Rs m | 2,081 | 6,791 | 30.6% | |
Net working cap to sales | % | 28.6 | 40.0 | 71.5% | |
Current ratio | x | 1.9 | 1.7 | 110.4% | |
Inventory Days | Days | 35 | 263 | 13.4% | |
Debtors Days | Days | 278 | 343 | 80.8% | |
Net fixed assets | Rs m | 878 | 10,617 | 8.3% | |
Share capital | Rs m | 227 | 166 | 136.9% | |
"Free" reserves | Rs m | 2,466 | 7,265 | 33.9% | |
Net worth | Rs m | 2,693 | 7,431 | 36.2% | |
Long term debt | Rs m | 25 | 0 | - | |
Total assets | Rs m | 4,842 | 22,330 | 21.7% | |
Interest coverage | x | 306.0 | 409.1 | 74.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.4 | 0.6 | 246.7% | |
Return on assets | % | 18.2 | 10.3 | 177.0% | |
Return on equity | % | 32.6 | 30.9 | 105.7% | |
Return on capital | % | 49.4 | 42.4 | 116.6% | |
Exports to sales | % | 0.1 | 0 | - | |
Imports to sales | % | 34.7 | 13.1 | 265.6% | |
Exports (fob) | Rs m | 8 | NA | - | |
Imports (cif) | Rs m | 2,281 | 1,605 | 142.1% | |
Fx inflow | Rs m | 8 | 1,465 | 0.5% | |
Fx outflow | Rs m | 2,298 | 1,605 | 143.2% | |
Net fx | Rs m | -2,291 | -140 | 1,633.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,188 | 2,360 | 50.4% | |
From Investments | Rs m | 287 | -215 | -133.4% | |
From Financial Activity | Rs m | -4,296 | -985 | 436.3% | |
Net Cashflow | Rs m | -2,821 | 1,160 | -243.1% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.1 | 51.8 | 98.6% | |
Indian inst/Mut Fund | % | 18.4 | 20.3 | 90.7% | |
FIIs | % | 0.0 | 7.6 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.9 | 48.2 | 101.5% | |
Shareholders | 25,706 | 56,730 | 45.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare WYETH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | WYETH | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.27% | -0.55% | 1.18% |
1-Month | 18.58% | -7.47% | -0.75% |
1-Year | 69.59% | -3.02% | 61.82% |
3-Year CAGR | 15.36% | -9.12% | 18.16% |
5-Year CAGR | 8.95% | 5.75% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the WYETH share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of WYETH hold a 51.1% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WYETH and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, WYETH paid a dividend of Rs 145.0 per share. This amounted to a Dividend Payout ratio of 374.7%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of WYETH, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.